Accord Healthcare is delighted to announce the launch of another High-Tech medicine to their already extensive portfolio of High-Tech medicines: Icatibant Accord 30 mg which comes in a pack of one 3 ml pre-filled syringe.
This medicine is indicated for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults, adolescents and children aged 2 years and older, with C1-esterase-inhibitor deficiency.
Please refer to the Summary of Product Characteristics (SPC) for further information. The SPC will be available from the launch date at www.hpra.ie and for Healthcare Professionals at www.accord-healthcare.ie.
Icatibant Accord will be available from both full-line wholesalers from launch. For further information please contact Accord in Cork on 021-461 9040 or visit www.accord-healthcare.ie
Think High-Techs, Think Accord
